Activation and evasion of antiviral innate immunity by hepatitis C virus - PubMed (original) (raw)

Review

Activation and evasion of antiviral innate immunity by hepatitis C virus

Stacy M Horner. J Mol Biol. 2014.

Abstract

Hepatitis C virus (HCV) chronically infects 130-170 million people worldwide and is a major public health burden. HCV is an RNA virus that infects hepatocytes within liver, and this infection is sensed as non-self by the intracellular innate immune response to program antiviral immunity to HCV. HCV encodes several strategies to evade this antiviral response, and this evasion of innate immunity plays a key role in determining viral persistence. This review discusses the molecular mechanisms of how the intracellular innate immune system detects HCV infection, including how HCV pathogen-associated molecular patterns are generated during infection and where they are recognized as foreign by the innate immune system. Further, this review highlights the key innate immune evasion strategies used by HCV to establish persistent infection within the liver, as well as how host genotype influences the outcome of HCV infection. Understanding these HCV-host interactions is key in understanding how to target HCV during infection and for the design of more effective HCV therapies at the immunological level.

Keywords: HCV; MAM; MAVS; RIG-I; interferon.

© 2013.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Innate immune sensing of HCV

Hallmarks of HCV infection can be sensed by pattern recognition receptors (PRRs) in a number of cell types within the liver to activate innate immunity. (A) HCV infection in hepatocytes is sensed by RIG-I, which detects the poly U/UC tract present in the 3’end of HCV RNA, and by TLR3, which detects dsRNA replication intermediates or HCV RNA that has been endocytosed from dying cells. These PRRs signal downstream to activate the innate immune response program, including the production of IFNβ, IFNλ, and pro-inflammatory cytokines, which act in an autocrine and paracrine manner to establish the full innate immune response. The red “X” indicates points of regulation of these signaling pathways by the HCV NS3/4A protease. (B) HCV is sensed in plasmacytoid dendritic cells (pDCs) by TLR7-mediated recognition of HCV RNA in the endosome. While pDCs themselves are not productively infected with HCV, the viral RNA is taken up by the pDC following exosomal transfer of viral RNA from productively infected hepatocytes. C) HCV can also be sensed in Kupffer cells, the liver resident macrophages, by the inflammasome signaling complex. Kupffer cells phagocytose HCV RNA (Signal 1) for TLR7-dependent signaling that activates the transcription of the pro-forms of IL-1β and IL-18, while potassium efflux (Signal 2) sensed by NLRP3 drives caspase 1 processing of IL-1β and IL-18 into the mature form for secretion and full activation of the inflammasome.

Similar articles

Cited by

References

    1. Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29(Suppl 1):74–81. - PubMed
    1. Soriano V, Peters MG, Zeuzem S. New therapies for hepatitis C virus infection. Clin Infect Dis. 2009;48:313–20. - PubMed
    1. Hofmann WP, Zeuzem S. A new standard of care for the treatment of chronic HCV infection. Nat Rev Gastroenterol Hepatol. 2011;8:257–64. - PubMed
    1. Sarrazin C, Hezode C, Zeuzem S, Pawlotsky JM. Antiviral strategies in hepatitis C virus infection. J Hepatol. 2012;56(Suppl):S88–S100. - PubMed
    1. Liang TJ. Current progress in development of hepatitis C virus vaccines. Nat Med. 2013;19:869–78. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources